申请人:Catabasis Pharmaceuticals, Inc.
公开号:US20160083336A1
公开(公告)日:2016-03-24
The invention relates to fatty acid acylated salicylate derivatives; compositions comprising an effective amount of a fatty acid acylated salicylate derivative; and methods for treating or preventing an inflammatory disorder comprising the administration of an effective amount of a fatty acid acylated salicylate derivative.
该发明涉及脂肪酸酰化水杨酸衍生物;包含有效量的脂肪酸酰化水杨酸衍生物的组合物;以及治疗或预防炎症性疾病的方法,其中包括给予有效量的脂肪酸酰化水杨酸衍生物的管理。